NCT01115426View on ClinicalTrials.gov

Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 1997

Primary Completion Date

January 31, 2007

Study Completion Date

January 31, 2008

Conditions
IGA Glomerulonephritis
Interventions
DRUG

Ramipril or losartan

Ramipril (5 mg/day) was started soon after the enrollment and continued throughout the follow-up, having Losartan (50 mg/day) as alternative.

Trial Locations (1)

88100

"Mater Domini Hospital", Catanzaro

All Listed Sponsors
lead

University Magna Graecia

OTHER

NCT01115426 - Inhibitors of Angiotensin II in Proteinuric Mesangioproliferative Glomerulonephritis | Biotech Hunter | Biotech Hunter